11 – 20 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Discovery of a novel B-Raf fusion protein related to c-Met drug resistance
- Contribution to journal › Article
-
Mark
MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells
- Contribution to journal › Article
-
Mark
Global microRNA analysis of the NCI-60 cancer cell panel
- Contribution to journal › Article
-
Mark
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
- Contribution to journal › Article
-
Mark
The role of RANK-ligand inhibition in cancer : the story of denosumab
- Contribution to journal › Scientific review
- 2009
-
Mark
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
- Contribution to journal › Article
-
Mark
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
- Contribution to journal › Article
- 2008
-
Mark
Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil
- Contribution to journal › Article
-
Mark
Role of homologous recombination in trabectedin-induced DNA damage
- Contribution to journal › Article
